Birdwatch Archive

Birdwatch Note

2024-08-17 14:01:53 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Il n'existe aucune trace d'essai clinique du TRANILAST (nom: commercial: RIZABEN) pour une utilisation dans le cadre du MPox, ni sur la base de données clinicaltrials, ni sur le site du fabriquant, ni sur le site de l'importateur européen. https://www.clinicaltrials.gov/search?term=TRANILAST&viewType=Table&page=1 https://www.kissei.co.jp/e_contents/news/2024/ https://www.sigmaaldrich.com/FR/fr/product/mm/616400m

Written by 1F8D116AE843FD049465FBD164199080875472B38B7CF38BF0D362E67D1423A4
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824785643764883475

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1824808874081218637
  • noteId - 1824808874081218637
  • participantId -
  • noteAuthorParticipantId - 1F8D116AE843FD049465FBD164199080875472B38B7CF38BF0D362E67D1423A4 Participant Details
  • createdAtMillis - 1723903313548
  • tweetId - 1824785643764883475
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Il n'existe aucune trace d'essai clinique du TRANILAST (nom: commercial: RIZABEN) pour une utilisation dans le cadre du MPox, ni sur la base de données clinicaltrials, ni sur le site du fabriquant, ni sur le site de l'importateur européen. https://www.clinicaltrials.gov/search?term=TRANILAST&viewType=Table&page=1 https://www.kissei.co.jp/e_contents/news/2024/ https://www.sigmaaldrich.com/FR/fr/product/mm/616400m

Note Ratings

rated at rated by
2024-08-21 02:01:32 -0500 Rating Details
2024-08-20 17:59:50 -0500 Rating Details
2024-08-20 17:28:49 -0500 Rating Details
2024-08-19 07:25:13 -0500 Rating Details
2024-08-18 06:19:53 -0500 Rating Details
2024-08-18 05:30:51 -0500 Rating Details
2024-08-18 05:20:38 -0500 Rating Details
2024-08-18 04:28:39 -0500 Rating Details
2024-08-18 04:23:33 -0500 Rating Details
2024-08-18 04:04:20 -0500 Rating Details
2024-08-18 03:51:28 -0500 Rating Details
2024-08-18 03:33:31 -0500 Rating Details
2024-08-18 03:26:53 -0500 Rating Details
2024-08-18 03:12:18 -0500 Rating Details
2024-08-18 03:05:40 -0500 Rating Details
2024-08-18 00:23:42 -0500 Rating Details
2024-08-17 23:01:15 -0500 Rating Details
2024-08-17 22:00:52 -0500 Rating Details
2024-08-17 16:33:58 -0500 Rating Details
2024-08-17 15:54:22 -0500 Rating Details
2024-08-17 15:45:17 -0500 Rating Details
2024-08-17 15:28:54 -0500 Rating Details
2024-08-17 15:14:05 -0500 Rating Details
2024-08-17 14:45:34 -0500 Rating Details
2024-08-17 14:28:27 -0500 Rating Details
2024-08-17 14:16:47 -0500 Rating Details
2024-08-17 13:34:27 -0500 Rating Details
2024-08-17 13:17:44 -0500 Rating Details
2024-08-17 12:57:57 -0500 Rating Details
2024-08-17 12:50:22 -0500 Rating Details
2024-08-17 12:43:49 -0500 Rating Details
2024-08-17 12:32:41 -0500 Rating Details
2024-08-17 12:29:15 -0500 Rating Details
2024-08-17 12:17:30 -0500 Rating Details
2024-08-17 12:15:57 -0500 Rating Details
2024-08-17 12:10:53 -0500 Rating Details
2024-08-17 12:10:48 -0500 Rating Details
2024-08-17 11:58:31 -0500 Rating Details
2024-08-17 11:49:56 -0500 Rating Details
2024-08-17 11:37:53 -0500 Rating Details
2024-08-17 11:29:14 -0500 Rating Details
2024-08-17 11:28:41 -0500 Rating Details
2024-08-17 11:19:29 -0500 Rating Details
2024-08-17 11:17:00 -0500 Rating Details
2024-08-17 10:53:53 -0500 Rating Details
2024-08-17 10:39:28 -0500 Rating Details
2024-08-17 10:36:19 -0500 Rating Details
2024-08-17 10:33:47 -0500 Rating Details
2024-08-17 10:30:39 -0500 Rating Details
2024-08-17 10:29:31 -0500 Rating Details
2024-08-17 10:28:34 -0500 Rating Details
2024-08-17 10:26:31 -0500 Rating Details
2024-08-17 10:22:49 -0500 Rating Details
2024-08-17 10:18:17 -0500 Rating Details
2024-08-17 10:08:50 -0500 Rating Details
2024-08-17 10:08:31 -0500 Rating Details
2024-08-17 10:05:49 -0500 Rating Details
2024-08-17 10:03:12 -0500 Rating Details
2024-08-17 09:57:55 -0500 Rating Details
2024-08-17 09:57:14 -0500 Rating Details
2024-08-17 09:51:44 -0500 Rating Details
2024-08-17 09:30:45 -0500 Rating Details
2024-08-17 09:23:51 -0500 Rating Details
2024-08-17 09:22:23 -0500 Rating Details
2024-08-17 09:07:37 -0500 Rating Details
2024-08-19 03:00:53 -0500 Rating Details
2024-08-18 11:17:37 -0500 Rating Details
2024-08-18 04:49:25 -0500 Rating Details
2024-08-17 23:55:28 -0500 Rating Details
2024-08-17 16:51:38 -0500 Rating Details
2024-08-17 16:18:46 -0500 Rating Details
2024-08-17 15:31:46 -0500 Rating Details
2024-08-17 13:46:55 -0500 Rating Details
2024-08-17 13:33:53 -0500 Rating Details
2024-08-17 13:29:14 -0500 Rating Details
2024-08-17 12:26:18 -0500 Rating Details
2024-08-17 11:24:58 -0500 Rating Details
2024-08-17 10:12:14 -0500 Rating Details
2024-08-17 10:09:37 -0500 Rating Details
2024-08-17 09:50:25 -0500 Rating Details
2024-08-17 09:48:32 -0500 Rating Details